Lupus registries: evolution and challenges
- PMID: 18992923
- DOI: 10.1016/j.semarthrit.2008.08.009
Lupus registries: evolution and challenges
Abstract
Objectives: To review the current status of lupus registries, highlight the importance and evolution of registries in clinical lupus research, discuss substantial advances in the understanding of lupus through the use of registries, and discuss the future role of registries in terms of opportunities and challenges.
Methods: The literature reviewed originated from the PubMed database and was limited to adult disease in articles published before June 01, 2008. Keywords used in the PubMed search included the following terms: systemic lupus erythematosus, registry, cohort, and database. All articles were sorted and analyzed according to a template devised by the authors describing the different types of registries.
Results: The most important features of a lupus registry are that they contain a large number of subjects and reflect a relatively real world environment for lupus patients. Data obtained from the lupus registries are essential for planning, designing, and conducting clinical lupus studies, especially those difficult, inappropriate, or even unethical to study in randomized controlled trials. Up to now, some well-conducted registries have received recognition for their contributions to lupus research through their focus on different goals: epidemiology, genetics, ethnic diversity, clinical features, or outcomes. Although they have evolved in design and study emphasis steadily, there are still many issues left to resolve. Apart from the development and future direction of the lupus registry, attention needs to be applied to normalizing the ethical and legal rules involving a lupus registry.
Conclusions: Lupus registries have demonstrated high standards and achieved much success through decades of effort, but they are still in an active state of evolution as they address more questions with greater clarity and sophistication.
(c) 2010 Elsevier Inc. All rights reserved.
Similar articles
-
The NCI All Ireland Cancer Conference.Oncologist. 1999;4(4):275-277. Oncologist. 1999. PMID: 10545862
-
The Italian Registry of Antiphospholipid Antibodies.Haematologica. 1997 Jan-Feb;82(1):101-5. Haematologica. 1997. PMID: 9107095 Review.
-
Outcome measures to be used in clinical trials in systemic lupus erythematosus.J Rheumatol. 1999 Feb;26(2):490-7. J Rheumatol. 1999. PMID: 9972993
-
Utilizing registries in systemic lupus erythematosus clinical research.Expert Rev Clin Immunol. 2012 May;8(4):353-60. doi: 10.1586/eci.12.20. Expert Rev Clin Immunol. 2012. PMID: 22607181 Review.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
Cited by
-
Barriers and facilitators for the implementation of health condition and outcome registry systems: a systematic literature review.J Am Med Inform Assoc. 2022 Mar 15;29(4):723-734. doi: 10.1093/jamia/ocab293. J Am Med Inform Assoc. 2022. PMID: 35022765 Free PMC article.
-
Review: Male systemic lupus erythematosus: a review of sex disparities in this disease.Lupus. 2010 Feb;19(2):119-29. doi: 10.1177/0961203309350755. Epub 2009 Nov 27. Lupus. 2010. PMID: 19946032 Free PMC article. Review.
-
Lessons learned from hemolytic uremic syndrome registries: recommendations for implementation.Orphanet J Rare Dis. 2021 May 25;16(1):240. doi: 10.1186/s13023-021-01871-9. Orphanet J Rare Dis. 2021. PMID: 34034793 Free PMC article.
-
Indian SLE Inception cohort for Research (INSPIRE): the design of a multi-institutional cohort.Rheumatol Int. 2021 May;41(5):887-894. doi: 10.1007/s00296-020-04766-3. Epub 2021 Jan 12. Rheumatol Int. 2021. PMID: 33433731
-
Lupus Cohorts.Rheum Dis Clin North Am. 2021 Aug;47(3):457-479. doi: 10.1016/j.rdc.2021.04.009. Epub 2021 Jun 10. Rheum Dis Clin North Am. 2021. PMID: 34215374 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical